2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Adjuvant Therapy in HER2+ BC: Utilizing T-DM1 for Pts With Residual Disease vs. Extending Adjuvant Therapy With 1 yr of Neratinib vs. Adding Pertuzumab + SoC Trastuzumab - Which Option Provides Better Results?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Reshma L. Mahtani
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Reshma L. Mahtani
21 views
July 13, 2020
Login to view comments.
Click here to Login
Breast